Top

BMC Psychiatry

Published in:

Open Access 01-12-2021 | Mood Disorders | Research

Identifying factors associated with the hospital readmission rate among patients with major depressive disorder

Authors: Sharareh Parami, Leili Tapak, Jalal Poorolajal, Abbas Moghimbeigi, Ali Ghaleiha

Published in: BMC Psychiatry | Issue 1/2021

Abstract

Background

Major depressive disorder (MDD) is a common recurrent mental disorder and one of the leading causes of disability in the world. The recurrence of MDD is associated with increased psychological and social burden, limitations for the patient, family, and society; therefore, action to reduce and prevent the recurrence of this disorder or hospital readmissions for depression among the patients is essential.

Methods

The data of this retrospective cohort study were extracted from records of 1005 patients with MDD hospitalized in Farshchian hospital in Hamadan city, Iran (2011–2018). The hospital readmissions rate due to depression episodes was modeled using generalized Poisson regression (GPR). Demographic and clinical characteristics of the patients were considered as explanatory variables. SAS v9.4 was used (P < 0.05).

Results

A majority of the patients were male (66.37%). The mean (standard deviation) of age at onset of MDD and the average number of hospital readmissions were 32.39 (13.03) years and 0.53 (1.84), respectively (most patients (74.3%) did not experience hospital readmissions). According to the results of the GPR, the lower age at the onset of the disease (IRR = 1.02;P = 0.008), illiteracy (IRR = 2.06;P = 0.003), living in urban areas (IRR = 1.56;P = 0.015), history of psychiatric illnesses in the family (IRR = 1.75;P = 0.004), history of emotional problems (IRR = 1.42;P = 0.028) and having medical disorders (IRR = 1.44;P = 0.035) were positively associated with the number of hospitalizations.

Conclusion

According to our findings, urbanization, early onset of the disease, illiteracy, family history of mental illness, emotional problems, and medical disorders are among major risk factors associated with an increased number of hospital readmissions of MDD.

Available only for authorised users

World Health Organization. Depression 2018 [Available from: https://www.who.int/en/news-room/fact-sheets/detail/Depression. Accessed 28 Sept 2021.

Curran C, Knapp M, McDaid D, Tómasson K, Group M. Mental health and employment: an overview of patterns and policies across Western Europe. J Ment Health. 2007;16(2):195–209. https://doi.org/10.1080/09638230701279865.CrossRef

de Macedo-Soares MB, Moreno RA, Rigonatti SP, Lafer B. Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: a case series. J ECT. 2005;21(1):31–4. https://doi.org/10.1097/01.yct.0000148621.88104.f1.CrossRefPubMed

Modabber-Nia M-J, Shodjai-Tehrani H, Moosavi S-R, Jahanbakhsh-Asli N, Fallahi M. The prevalence of depression among high school and preuniversity adolescents: Rasht, northern Iran. Arch Iran Med. 2007;10(2):141–6.PubMed

Depression W. Other common mental disorders: global health estimates. Geneva: World Health Organization; 2017. p. 1–24.

Hasler G. Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatr. 2010;9(3):155–61. https://doi.org/10.1002/j.2051-5545.2010.tb00298.x.CrossRef

Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama. 2003;289(23):3095–105. https://doi.org/10.1001/jama.289.23.3095.CrossRefPubMed

McKnight PE, Kashdan TB. The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clin Psychol Rev. 2009;29(3):243–59. https://doi.org/10.1016/j.cpr.2009.01.005.CrossRefPubMedPubMedCentral

Katon W. The impact of depression on workplace functioning and disability costs. Am J Manag Care. 2009;15(11 Suppl):S322–7.PubMed

10.

Kennedy SH, Eisfeld BS, Cooke RG. Quality of life: an important dimension in assessing the treatment of depression? J Psychiatr Neurosci JPN. 2001;26(Suppl):S23.

11.

Sadock B, Sadock V, Ruiz P. Summary of psychiatry: behavioral sciences clinical psychoiatry. 11th ed. Tehran: Arjomand publications; 2015.

12.

Mullen S. Major depressive disorder in children and adolescents. Mental Health Clin. 2018;8(6):275–83. https://doi.org/10.9740/mhc.2018.11.275.CrossRef

13.

Kaplan BJ. Kaplan and Sadock’s synopsis of psychiatry. Behavioral sciences/clinical psychiatry. Tijdschrift voor Psychiatrie. 2016;58(1):347–86.

14.

Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatr. 1990;47(12):1093–9. https://doi.org/10.1001/archpsyc.1990.01810240013002.CrossRefPubMed

15.

Gonzales LR, Lewinsohn PM, Clarke GN. Longitudinal follow-up of unipolar depressives: an investigation of predictors of relapse. J Consult Clin Psychol. 1985;53(4):461–9. https://doi.org/10.1037/0022-006X.53.4.461.CrossRefPubMed

16.

Hollon SD, DeRubeis RJ, Evans MD, Wiemer MJ, Garvey MJ, Grove WM, et al. Cognitive therapy and pharmacotherapy for depression: singly and in combination. Arch Gen Psychiatr. 1992;49(10):774–81. https://doi.org/10.1001/archpsyc.1992.01820100018004.CrossRefPubMed

17.

Keller MB, Lavori PW, Lewis CE, Klerman GL. Predictors of relapse in major depressive disorder. Jama. 1983;250(24):3299–304. https://doi.org/10.1001/jama.1983.03340240025024.CrossRefPubMed

18.

Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatr. 1992.

19.

Roy-Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand. 1985;71(s317):1–33. https://doi.org/10.1111/j.1600-0447.1985.tb10510.x.CrossRef

20.

Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. 2007;27(8):959–85. https://doi.org/10.1016/j.cpr.2007.02.005.CrossRefPubMedPubMedCentral

21.

Judd LL. The clinical course of unipolar major depressive disorders. Arch Gen Psychiatr. 1997;54(11):989–91. https://doi.org/10.1001/archpsyc.1997.01830230015002.CrossRefPubMed

22.

Balkrishnan R, Joish VN, Yang T, Jayawant SS, Mullins CD. The economic burden associated with SSRI treatment failure in a managed care population. J Med Econ. 2008;11(4):601–10. https://doi.org/10.3111/13696990802522339.CrossRefPubMed

23.

Fostick L, Silberman A, Beckman M, Spivak B, Amital D. The economic impact of depression: resistance or severity? Eur Neuropsychopharmacol. 2010;20(10):671–5. https://doi.org/10.1016/j.euroneuro.2010.06.001.CrossRefPubMed

24.

Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatr. 2000;57(4):375–80. https://doi.org/10.1001/archpsyc.57.4.375.CrossRefPubMed

25.

Skodol AE, Grilo CM, Keyes KM, Geier T, Grant BF, Hasin DS. Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatr. 2011;168(3):257–64. https://doi.org/10.1176/appi.ajp.2010.10050695.CrossRefPubMed

26.

Kupfer DJ, Frank E, Wamhoff J. Mood disorders: Update on prevention of recurrence. In: Mundt C, Goldstein MJ, editors. Interpersonal factors in the origin and course of affective disorders. London, England: Gaskell/Royal College of Psychiatrists; 1996. pp. 289–302.

27.

Perris C. The distinction between unipolar and bipolar mood disorders: a 25-year perspective. L'Encéphale: Revue de psychiatrie clinique biologique et thérapeutique. 1992;18(1):9–13.

28.

Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatr. 2018;75(4):336–46. https://doi.org/10.1001/jamapsychiatry.2017.4602.CrossRef

29.

Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice. Am J Psychiatr. 2006;163(1):28–40. https://doi.org/10.1176/appi.ajp.163.1.28.CrossRefPubMed

30.

Cheung A, Mayes T, Levitt A, Schaffer A, Michalak E, Kiss A, et al. Anxiety as a predictor of treatment outcome in children and adolescents with depression. J Child Adolesc Psychopharmacol. 2010;20(3):211–6. https://doi.org/10.1089/cap.2010.0006.CrossRefPubMedPubMedCentral

31.

Barkow K, Maier W, Üstün TB, Gänsicke M, Wittchen H-U, Heun R. Risk factors for depression at 12-month follow-up in adult primary health care patients with major depression: an international prospective study. J Affect Disord. 2003;76(1–3):157–69. https://doi.org/10.1016/S0165-0327(02)00081-2.CrossRefPubMed

32.

Weinberger MI, Sirey JA, Bruce ML, Heo M, Papademetriou E, Meyers BS. Predictors of major depression six months after admission for outpatient treatment. Psychiatr Serv. 2008;59(10):1211–5. https://doi.org/10.1176/ps.2008.59.10.1211.CrossRefPubMedPubMedCentral

33.

Alwan A, Saeed K. A new agenda for mental health in the eastern Mediterranean region. EMHJ East Mediterr Health J. 2015;21(7):459–60. https://doi.org/10.26719/2015.21.7.459.CrossRefPubMed

34.

Haghgoo A, Zoladl M, Afroughi S, Rahimian H, Mirzaee MS. Assessment of the Burden on Family Caregivers of Patients with Mental Disorders Hospitalized in Shahid Rajai Hospital in Yasuj, 2016. Assessment. 2017;5(2):39–44.

35.

Halvorsen M, Wang CE, Eisemann M, Waterloo K. Dysfunctional attitudes and early maladaptive schemas as predictors of depression: a 9-year follow-up study. Cogn Ther Res. 2010;34(4):368–79. https://doi.org/10.1007/s10608-009-9259-5.CrossRef

36.

Saragoussi D, Touya M, Haro JM, Jönsson B, Knapp M, Botrel B, et al. Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study. Neuropsychiatr Dis Treat. 2017;13:2151–65. https://doi.org/10.2147/NDT.S136343.CrossRefPubMedPubMedCentral

37.

Gilman SE, Kawachi I, Fitzmaurice GM, Buka SL. Socio-economic status, family disruption and residential stability in childhood: relation to onset, recurrence and remission of major depression. Psychol Med. 2003;33(8):1341–55. https://doi.org/10.1017/S0033291703008377.CrossRefPubMed

38.

Vuong QH. Likelihood ratio tests for model selection and non-nested hypotheses. Econometrica: J Econometric Soc. 1989;57(2):307–33. https://doi.org/10.2307/1912557.CrossRef

39.

Sharareh P, Leili T, Abbas M, Jalal P, Ali G. Determining correlates of the average number of cigarette smoking among college students using count regression models. Sci Rep. 2020;10(1):1–10. https://doi.org/10.1038/s41598-020-65813-4.CrossRef

40.

Wainwright N, Surtees PG. Childhood adversity, gender and depression over the life-course. J Affect Disord. 2002;72(1):33–44. https://doi.org/10.1016/S0165-0327(01)00420-7.CrossRefPubMed

41.

Amiri S. Unemployment associated with major depression disorder and depressive symptoms: A systematic review and meta-analysis. In: International journal of occupational safety and ergonomics; 2021 (just-accepted). p. 1–43.

42.

McLeod JD, Kessler RC, Landis KR. Speed of recovery from major depressive episodes in a community sample of married men and women. J Abnorm Psychol. 1992;101(2):277–86. https://doi.org/10.1037/0021-843X.101.2.277.CrossRefPubMed

43.

Stegenga BT, Geerlings MI, Torres-González F, Xavier M, Švab I, Penninx BW, et al. Risk factors for onset of multiple or long major depressive episodes versus single and short episodes. Soc Psychiatry Psychiatr Epidemiol. 2013;48(7):1067–75. https://doi.org/10.1007/s00127-012-0626-2.CrossRefPubMed

44.

Zamanian Z, Riaei S, Kaveh N, Khosravani A, Sayadi M, Moemenbellah-Fard MD. The prevalence of Depression and its associated factors among students at Shiraz University of Medical Sciences in 2012. J Health Sci Surveill Syst. 2016;4(1):7–13.

45.

Chevalier A, Feinstein L. The causal effect of education on depression, 2004; 2005.

46.

Teraishi T, Hori H, Sasayama D, Matsuo J, Ogawa S, Ishida I, et al. Personality in remitted major depressive disorder with single and recurrent episodes assessed with the temperament and character inventory. Psychiatry Clin Neurosci. 2015;69(1):3–11. https://doi.org/10.1111/pcn.12218.CrossRefPubMed

47.

Pouretemad HR, Naghavi HR, Malekafzali H, Noorbala AA, Davidian H, Ghanizadeh A, et al. Prevalence of Mood Disorders in Iran. Iran J Psychiatry. 2006;1(2):59–64.

48.

Brown GW, Moran P. Clinical and psychosocial origins of chronic depressive episodes. Br J Psychiatr. 1994;165(4):447–56. https://doi.org/10.1192/bjp.165.4.447.CrossRef

49.

Brown GW, Moran P, Harris T, Hepworth C, Robinson R. Clinical and psychosocial origins of chronic depressive episodes: II: a patient enquiry. Br J Psychiatr. 1994;165(4):457–65. https://doi.org/10.1192/bjp.165.4.457.CrossRef

50.

Hynninen KMJ, Breitve MH, Wiborg AB, Pallesen S, Nordhus IH. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res. 2005;59(6):429–43. https://doi.org/10.1016/j.jpsychores.2005.04.007.CrossRefPubMed

51.

Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA. Determinants of persistence of major depressive episodes in the general population. Results from the Netherlands mental health survey and incidence study (NEMESIS). J Affect Disord. 2004;81(3):231–40. https://doi.org/10.1016/j.jad.2003.08.005.CrossRefPubMed

52.

Geerlings SW, Beekman AT, Deeg DJ, Van Tilburg W. Physical health and the onset and persistence of depression in older adults: an eight-wave prospective community-based study. Psychol Med. 2000;30(2):369–80. https://doi.org/10.1017/S0033291799001890.CrossRefPubMed

53.

Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, et al. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. J Clin Psychopharmacol. 2002;22(5):474–80. https://doi.org/10.1097/00004714-200210000-00006.CrossRefPubMed

54.

Rucci P, Frank E, Calugi S, Miniati M, Benvenuti A, Wallace M, et al. Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination. Depression and Anxiety. 2011;28(11):955–62. https://doi.org/10.1002/da.20894.CrossRefPubMed

55.

Hardeveld F, Spijker J, De Graaf R, Hendriks SM, Licht CM, Nolen WA, et al. Recurrence of major depressive disorder across different treatment settings: results from the NESDA study. J Affect Disord. 2013;147(1–3):225–31. https://doi.org/10.1016/j.jad.2012.11.008.CrossRefPubMed

56.

Onaemo VN, Fawehinmi TO, D’Arcy C. Alcohol use disorder and the persistence/recurrence of major Depression. Can J Psychiatr. 2020. https://doi.org/10.1177/0706743720923065.

57.

Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: a causal analysis. Arch Gen Psychiatr. 1993;50(1):36–43. https://doi.org/10.1001/archpsyc.1993.01820130038007.CrossRefPubMed

Title: Identifying factors associated with the hospital readmission rate among patients with major depressive disorder
Authors: Sharareh Parami
Leili Tapak
Jalal Poorolajal
Abbas Moghimbeigi
Ali Ghaleiha
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Mood Disorders
Affective Disorder
Published in: BMC Psychiatry / Issue 1/2021
Electronic ISSN: 1471-244X
DOI: https://doi.org/10.1186/s12888-021-03559-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Identifying factors associated with the hospital readmission rate among patients with major depressive disorder

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Time of onset and/or diagnosis of ADHD in European children: a systematic review

Predicting diagnostic outcome in adult autism spectrum disorder using the autism diagnostic observation schedule, second edition

Recognizing obsessive-compulsive disorder: how suitable is the German Zohar-Fineberg obsessive-compulsive screen?

Anhedonia difference between major depressive disorder and bipolar disorder II

Therapists’ emotional state after sessions in which suicidality is addressed: need for improved management of suicidal tendencies in patients with borderline personality pathology

Association of depression symptom severity with short-term risk of an initial hospital encounter in adults with major depressive disorder